Poland· PL-100052962
Pigmentum Castellani
A antiseptics and disinfectants product containing phenolum + resorcinolum + acidum boricum, registered in Poland by Chema-Elektromet Spółdzielnia Pracy.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Phenolum + Resorcinolum + Acidum boricum
- Manufacturer
- Chema-Elektromet Spółdzielnia Pracy
- Country
- Poland (PL)
- ATC code
- D08
- ATC class
- ANTISEPTICS AND DISINFECTANTS
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990267811
- gtin05909990267828
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/357eeaed-7f68-496b-81d4-e16713c8cab6 GET /v1/drugs/357eeaed-7f68-496b-81d4-e16713c8cab6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Płyn na skórę",
"source": "urpl",
"strength": "(40 mg + 80 mg + 8 mg)/g",
"packaging": "05909990267811 ¦ OTC ¦ 7956\n1 butelka 50 g\n05909990267828 ¦ OTC ¦ 61263\n1 butelka 125 g",
"substance": "Phenolum 40 mg/g + Resorcinolum 80 mg/g + Acidum boricum 8 mg/g",
"common_name": "Phenolum + Resorcinolum + Acidum boricum",
"pl_product_id": "100052962",
"pozwolenie_nr": "02678",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about phenolum + resorcinolum + acidum boricum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.